Biocompatibility of Chitosan Carriers with Application in Drug Delivery

Chitosan is one of the most used polysaccharides in the design of drug delivery strategies for administration of either biomacromolecules or low molecular weight drugs. For these purposes, it is frequently used as matrix forming material in both nano and micron-sized particles. In addition to its in...

Full description

Bibliographic Details
Main Authors: Ana Grenha, Susana Rodrigues, Carmen Remuñán López, Marita Dionísio
Format: Article
Language:English
Published: MDPI AG 2012-09-01
Series:Journal of Functional Biomaterials
Subjects:
Online Access:http://www.mdpi.com/2079-4983/3/3/615
id doaj-1e0f9c9b75cf455d9291f71210472e03
record_format Article
spelling doaj-1e0f9c9b75cf455d9291f71210472e032020-11-24T23:46:09ZengMDPI AGJournal of Functional Biomaterials2079-49832012-09-013361564110.3390/jfb3030615Biocompatibility of Chitosan Carriers with Application in Drug DeliveryAna GrenhaSusana RodriguesCarmen Remuñán LópezMarita DionísioChitosan is one of the most used polysaccharides in the design of drug delivery strategies for administration of either biomacromolecules or low molecular weight drugs. For these purposes, it is frequently used as matrix forming material in both nano and micron-sized particles. In addition to its interesting physicochemical and biopharmaceutical properties, which include high mucoadhesion and a great capacity to produce drug delivery systems, ensuring the biocompatibility of the drug delivery vehicles is a highly relevant issue. Nevertheless, this subject is not addressed as frequently as desired and even though the application of chitosan carriers has been widely explored, the demonstration of systems biocompatibility is still in its infancy. In this review, addressing the biocompatibility of chitosan carriers with application in drug delivery is discussed and the methods used in vitro and in vivo, exploring the effect of different variables, are described. We further provide a discussion on the pros and cons of used methodologies, as well as on the difficulties arising from the absence of standardization of procedures.http://www.mdpi.com/2079-4983/3/3/615biocompatibilitychitosancytotoxicitygenotoxicitymicroparticlesnanoparticles
collection DOAJ
language English
format Article
sources DOAJ
author Ana Grenha
Susana Rodrigues
Carmen Remuñán López
Marita Dionísio
spellingShingle Ana Grenha
Susana Rodrigues
Carmen Remuñán López
Marita Dionísio
Biocompatibility of Chitosan Carriers with Application in Drug Delivery
Journal of Functional Biomaterials
biocompatibility
chitosan
cytotoxicity
genotoxicity
microparticles
nanoparticles
author_facet Ana Grenha
Susana Rodrigues
Carmen Remuñán López
Marita Dionísio
author_sort Ana Grenha
title Biocompatibility of Chitosan Carriers with Application in Drug Delivery
title_short Biocompatibility of Chitosan Carriers with Application in Drug Delivery
title_full Biocompatibility of Chitosan Carriers with Application in Drug Delivery
title_fullStr Biocompatibility of Chitosan Carriers with Application in Drug Delivery
title_full_unstemmed Biocompatibility of Chitosan Carriers with Application in Drug Delivery
title_sort biocompatibility of chitosan carriers with application in drug delivery
publisher MDPI AG
series Journal of Functional Biomaterials
issn 2079-4983
publishDate 2012-09-01
description Chitosan is one of the most used polysaccharides in the design of drug delivery strategies for administration of either biomacromolecules or low molecular weight drugs. For these purposes, it is frequently used as matrix forming material in both nano and micron-sized particles. In addition to its interesting physicochemical and biopharmaceutical properties, which include high mucoadhesion and a great capacity to produce drug delivery systems, ensuring the biocompatibility of the drug delivery vehicles is a highly relevant issue. Nevertheless, this subject is not addressed as frequently as desired and even though the application of chitosan carriers has been widely explored, the demonstration of systems biocompatibility is still in its infancy. In this review, addressing the biocompatibility of chitosan carriers with application in drug delivery is discussed and the methods used in vitro and in vivo, exploring the effect of different variables, are described. We further provide a discussion on the pros and cons of used methodologies, as well as on the difficulties arising from the absence of standardization of procedures.
topic biocompatibility
chitosan
cytotoxicity
genotoxicity
microparticles
nanoparticles
url http://www.mdpi.com/2079-4983/3/3/615
work_keys_str_mv AT anagrenha biocompatibilityofchitosancarrierswithapplicationindrugdelivery
AT susanarodrigues biocompatibilityofchitosancarrierswithapplicationindrugdelivery
AT carmenremunanlopez biocompatibilityofchitosancarrierswithapplicationindrugdelivery
AT maritadionisio biocompatibilityofchitosancarrierswithapplicationindrugdelivery
_version_ 1725494346784964608